Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.78 |
| ▸ | MAOA | P21397 | 13/20 | 0.78 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25211002 | 0.88 | MAOA (1.00) | MAOBMAOARXFP1ALDH1A1MAPT | |
| SCHEMBL30423044 | 0.88 | MAOA (1.00) | MAOBMAOARXFP1ALDH1A1MAPT | |
| SCHEMBL25228419 | 0.87 | MAOB (1.00) | MAOBMAOARXFP1ALDH1A1MAPT | |
| SCHEMBL25206902 | 0.82 | MAOB (1.00) | MAOBMAOARXFP1ALDH1A1MAPT | |
| SCHEMBL25204680 | 0.81 | MAOB (0.71) | MAOBMAOARXFP1ALDH1A1MAPT | |
| SCHEMBL25199656 | 0.81 | MAOB (0.71) | MAOBMAOARXFP1MEN1KMT2A | |
| SCHEMBL30422270 | 0.81 | MAOB (1.00) | MAOBMAOARXFP1KMT2APOLB | |
| SCHEMBL25234505 | 0.81 | MAOB (1.00) | MAOBMAOARXFP1KMT2APOLB | |
| SCHEMBL28341480 | 0.81 | MAOB (0.79) | MAOBMAOARXFP1MEN1KMT2A | |
| SCHEMBL25241173 | 0.80 | MAOB (1.00) | MAOBMAOARXFP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11666577-B2 | MLKL inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2023-06-06 | — | — | US | disclosed |
| CN-110573509-B | MLKL inhibitors | 北京生命科学研究所 | 2023-05-26 | — | — | CN | disclosed |
| CN-110573509-A | MLKL inhibitors | 北京生命科学研究所 | 2019-12-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666577-B2 | MLKL inhibitors | MLKL, CMKLR1, PCSK9 | MAOB 4517/4885MAOA 4584/4885RXFP1 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.